Ligang Zhang, PhD

Vice President, DS Process Development at Alnylam Pharmaceuticals

Speaker

Ligang Zhang is VP, Process Sciences from Alnylam Pharmaceuticals. Her career extends from drug substance process development to broader CMC development. Currently, Ligang oversees drug substance process sciences team, responsible for developing and advancing robust, scalable manufacturing processes across Alnylam’s entire siRNA portfolio, working with a diverse range of chemical modifications and modalities. Notably, she has led process development efforts for all five approved GalNAc-conjugated siRNA therapeutics from Alnylam. Her teams’ work bridges early discovery and late-stage development.

Ligang received her PhD from Peking University, Health Science Center in China. She did her postdoc at Northwestern University under Dr. Bob Letsinger.